Creative Planning Celldex Therapeutics, Inc. Transaction History

Creative Planning

$93.6 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$35.22 - $51.88 $643,152 - $947,380	-18,261 Reduced 78.69%	4,944 $207,000
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $53,879 - $96,868	2,383 Added 11.44%	23,205 $920,000
Q3 2023 Nov 16, 2023	BUY	$25.45 - $37.46 $13,997 - $20,603	550 Added 2.71%	20,822 $573,000
Q2 2023 Jul 21, 2023	BUY	$30.29 - $38.28 $393 - $497	13 Added 0.06%	20,272 $687,000
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $3,860 - $5,264	111 Added 0.55%	20,259 $728,000
Q4 2022 Feb 10, 2023	BUY	$27.78 - $45.38 $9,528 - $15,565	343 Added 1.73%	20,148 $897,000
Q3 2022 Nov 03, 2022	BUY	$22.7 - $37.57 $1,203 - $1,991	53 Added 0.27%	19,805 $557,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $902 - $1,642	44 Added 0.22%	19,752 $533,000
Q4 2021 Feb 11, 2022	SELL	$35.68 - $56.27 $156,992 - $247,588	-4,400 Reduced 18.25%	19,708 $762,000
Q2 2021 Aug 04, 2021	SELL	$20.71 - $35.37 $807 - $1,379	-39 Reduced 0.16%	24,108 $806,000
Q1 2021 Apr 30, 2021	SELL	$16.19 - $29.91 $178,090 - $329,010	-11,000 Reduced 31.3%	24,147 $497,000
Q4 2020 Jan 29, 2021	SELL	$14.99 - $22.75 $2,998 - $4,550	-200 Reduced 0.57%	35,147 $616,000
Q2 2020 Jul 23, 2020	BUY	$1.61 - $13.41 $37,352 - $311,112	23,200 Added 190.99%	35,347 $460,000
Q4 2019 Jan 30, 2020	SELL	$2.11 - $2.8 $884 - $1,173	-419 Reduced 3.33%	12,147 $27,000
Q3 2019 Nov 01, 2019	BUY	$2.05 - $2.75 $108 - $145	53 Added 0.42%	12,566 $27,000
Q2 2019 Jul 26, 2019	BUY	$2.43 - $5.09 $729 - $1,527	300 Added 2.46%	12,513 $34,000
Q1 2019 Apr 24, 2019	BUY	$3.45 - $10.35 $42,134 - $126,404	12,213 New	12,213 $60,000

Others Institutions Holding CLDX

# of Institutions

195

Shares Held

63.4M

Call Options Held

206K

Put Options Held

176K

Wellington Management Group LLP Boston, MA

8.08M
Shares

$268 Million
0.05% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$156 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.74M
Shares

$124 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.39M
Shares

$113 Million
9.76% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$110 Million
2.17% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.55B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account